Current hormone therapy associated with atypical squamous cells of undetermined significance in postmenopausal women

International Journal of Gynecological Cancer

Volumn 19, Issue 4, 2009, Pages 699-702

  Ahn, Ki Hoon ^a   Kim, Tak ^a   Kim, Young Tae ^a   Lee, Kyu Wan ^a   Kim, Sun Haeng ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Hormone therapy; Liquid based cytology; Postmenopause; Uterine cervix

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; AGED; ARTICLE; ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE; CELL DAMAGE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HORMONAL THERAPY; HUMAN; KOREA; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE;

ADULT; AGED; AGED, 80 AND OVER; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; UTERINE CERVICAL NEOPLASMS;

EID: 67651017975     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e31819d8b5b     Document Type: Article

References (18)

1. SOG Gynecologic Oncology Committee. Annual report of gynecologic cancer registry program in Korea for 2004 (Jan. 1st, 2004-Dec. 31st, 2004). Korean J Obstet Gynecol. 2007;50:28-78. [in Korean].
2. Ford LC, Berek JS, Lagasse LD, et al. Estrogen and progesterone receptor sites in malignancies of the uterine cervix, vagina, and vulva. Gynecol Oncol. 1983;15:27-31.
3. Monsonego J, Magdelenat H, Catalan F, et al. Estrogen and progesterone receptors in cervical human papillomavirus related lesions. Int J Cancer. 1991;48:533-539.
4. Vessey M, Yeates D. Oral contraceptives and benign breast disease: an update of findings in a large cohort study. Contraception. 2007;76: 418-424.
5. Yasmeen S, Romano PS, Pettinger M, et al. Incidence of cervical cytological abnormalities with aging in the Women's Health Initiative: a randomized controlled trial. Obstet Gynecol. 2006;108:410-419.
6. Sawaya GF, Grady D, Kerlikowske K, et al. The positive predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen/progestin Replacement Study (HERS). Ann Intern Med. 2000;133:942-950.
7. Wright TC Jr., Cox JT, Massad LS, et al. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287:2120-2129.
8. Lima CA, Palmeira JA, Cipolotti R. Risk factors for cancer of the uterine cervix in Propria, Sergipe, Brazil [in Portuguese]. Cad Saude Publica. 2006;22:2151-2156.
9. Nair HB, Luthra R, Kirma N, et al. Induction of aromatase expression in cervical carcinomas: effects of endogenous estrogen on cervical cancer cell proliferation. Cancer Res. 2005;65:11164-11173.
10. Arbeit JM, Howley PM, Hanahan D. Chronic estrogen-induced cervical and vaginal squamous carcinogenesis in human papillomavirus type 16 transgenic mice. Proc Natl Acad Sci U S A. 1996;93:2930-2935.
11. Ferenczy A, Gelfand MM, Franco E, et al. Human papillomavirus infection in postmenopausal women with and without hormone therapy. Obstet Gynecol. 1997;90:7-11.
12. Rader AE, Rose PG, Rodriguez M, et al. Atypical squamous cells of undetermined significance in women over 55. Comparison with the general population and implications for management. Acta Cytol. 1999;43:357-362.
13. Saminathan T, Lahoti C, Kannan V, et al. Postmenopausal squamous-cell atypias: a diagnostic challenge. Diagn Cytopathol. 1994;11:226-230.
14. Parazzini F, La Vecchia C, Negri E, et al. Case-control study of oestrogen replacement therapy and risk of cervical cancer. BMJ. 1997;315:85-88.
15. Lacey JV Jr., Brinton LA, Barnes WA, et al. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol Oncol. 2000;77:149-154.
16. Gupta S, Kumar N, Singhal N, et al. Cytohormonal and morphological alterations in cervicovaginal smears of postmenopausal women on hormone replacement therapy. Diagn Cytopathol. 2006;34:676-681.
17. Moss S, Gray A, Legood R, et al. Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study. BMJ. 2006;332:83-85.
18. Wright TC Jr., Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. J Low Genit Tract Dis. 2007; 11:223-239.